The company
Jade Biosciences, Inc.
JBIO · Nasdaq
JBIO stood above a rising 150-day average in 35 of the last 52 weekly readings, and has been out of that trend for the last 6 weeks. It is 28.7% below that average now. Biotechnology: 16% of its 561 stocks in an uptrend (−15 points in four weeks); Health Care: 26% (−10 points in four weeks).
Statistics
- Rotation
- Not moving yet
- Weeks in an uptrend
- out for 6
- Industry in uptrend
- 16% -15 in 4 wk
- Insider buys, 12 months
- $0
- Insider sales, 12 months
- $0
- Officials’ trades on record
- 0
- Institutions holding
- 147 (+33)
In the rotation
Each square a week: lit when it closed above a rising 150-day average. 35 of 52 weeks.
Biotechnology: Few of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.
Money in and out
Open-market buys above the line and sales below, in dollars.
Congress and officials
No member of Congress or official has disclosed a trade in it.
Insiders
No open-market buy or sale by its insiders on record.
Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.
Institutions
Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.
| Manager | Shares | Change |
|---|---|---|
| FMR LLCadded · filed 13 Aug 2026 | 9,126,877$202.8M | +2,041,454+28.8% |
| Jupiter Topco LLCnew · filed 14 Aug 2026 | 6,273,262$139.4M | +6,273,262 |
| Fairmount Funds Management LLCunchanged · filed 14 Aug 2026 | 4,553,494$101.2M | 00.0% |
| RA CAPITAL MANAGEMENT, L.P.unchanged · filed 14 Aug 2026 | 3,671,083$81.6M | 00.0% |
| Venrock Adviser, LLCunchanged · filed 14 Aug 2026 | 3,220,364$71.6M | 00.0% |
| Bellevue Group AGreduced · filed 14 Aug 2026 | 3,057,996$67.9M | -443,506−12.7% |
| Paradigm Biocapital Advisors LPnew · filed 14 Aug 2026 | 2,857,405$63.5M | +2,857,405 |
| BlackRock, Inc.added · filed 7 Aug 2026 | 2,801,451$62.2M | +487,502+21.1% |
| FRANKLIN RESOURCES INCnew · filed 13 Aug 2026 | 2,792,080$62.0M | +2,792,080 |
| STATE STREET CORPadded · filed 7 Aug 2026 | 2,335,285$51.9M | +1,679,595+256.2% |
News
Everyone who traded it
Same industry
Government contracts
No federal award is tied to it.
From its SEC filings
Analyst forecasts
No analyst forecasts yet.